B-CELL NON HODGKIN LYMPHOMA
Clinical trials for B-CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Punch immunotherapy trial aims to tame resistant blood cancer
Disease control OngoingThis study is testing a combination of two advanced immunotherapies for people with B-cell Non-Hodgkin lymphoma that has come back or not responded to standard treatments. The goal is to see if using a bispecific antibody drug together with engineered immune cells (CAR-T cells) i…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope to tame the storm: drug trial aims to shield patients from CAR-T's worst side effects
Disease control OngoingThis study is testing if a drug called anakinra can prevent or reduce severe brain-related side effects and dangerous immune reactions in adults receiving CAR-T cell therapy for certain B-cell cancers. The goal is to make this powerful cancer treatment safer by controlling its mo…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Double-Punch combo trial aims to boost Cancer-Killing power
Disease control OngoingThis study is testing whether adding a pill called acalabrutinib makes a powerful cell therapy (CAR-T) work better and safer for people with certain aggressive B-cell lymphomas. The trial enrolled 23 adults to see if the combination is safe and can help control the cancer. Resear…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Simple blood test could replace scans for cancer monitoring
Diagnosis OngoingThis study is testing whether a blood test can detect if aggressive B-cell lymphoma has returned after chemotherapy treatment. Researchers want to see if this test can predict relapse earlier than standard scans and exams. If successful, it could help patients avoid frequent imag…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
Simple blood test could predict Lymphoma's return
Knowledge-focused OngoingThis study aims to see if tracking tiny pieces of tumor DNA in the blood can help predict how well lymphoma treatment is working and whether the cancer might come back. Researchers will collect blood samples from 60 patients with B-cell non-Hodgkin lymphoma before, during, and af…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC